DK0796622T3 - Anvendelse af en gonadotropin-frigivende hormonanalog eller efterligning deraf til fremstilling af et farmaceutisk præparat som et supplement til den invasive behandling af carcinomer - Google Patents

Anvendelse af en gonadotropin-frigivende hormonanalog eller efterligning deraf til fremstilling af et farmaceutisk præparat som et supplement til den invasive behandling af carcinomer

Info

Publication number
DK0796622T3
DK0796622T3 DK97104590T DK97104590T DK0796622T3 DK 0796622 T3 DK0796622 T3 DK 0796622T3 DK 97104590 T DK97104590 T DK 97104590T DK 97104590 T DK97104590 T DK 97104590T DK 0796622 T3 DK0796622 T3 DK 0796622T3
Authority
DK
Denmark
Prior art keywords
releasing hormone
gonadotropin
adjunct
carcinomas
mimic
Prior art date
Application number
DK97104590T
Other languages
English (en)
Inventor
Gary D Hodgen
Original Assignee
Eastern Virginia Med School
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24472058&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0796622(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eastern Virginia Med School filed Critical Eastern Virginia Med School
Application granted granted Critical
Publication of DK0796622T3 publication Critical patent/DK0796622T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK97104590T 1996-03-18 1997-03-18 Anvendelse af en gonadotropin-frigivende hormonanalog eller efterligning deraf til fremstilling af et farmaceutisk præparat som et supplement til den invasive behandling af carcinomer DK0796622T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/617,048 US5691314A (en) 1996-03-18 1996-03-18 Adjunctive therapy

Publications (1)

Publication Number Publication Date
DK0796622T3 true DK0796622T3 (da) 2004-01-12

Family

ID=24472058

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97104590T DK0796622T3 (da) 1996-03-18 1997-03-18 Anvendelse af en gonadotropin-frigivende hormonanalog eller efterligning deraf til fremstilling af et farmaceutisk præparat som et supplement til den invasive behandling af carcinomer

Country Status (7)

Country Link
US (2) US5691314A (da)
EP (1) EP0796622B1 (da)
AT (1) ATE249233T1 (da)
DE (1) DE69724682T2 (da)
DK (1) DK0796622T3 (da)
ES (1) ES2206622T3 (da)
PT (1) PT796622E (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780435A (en) 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists
US6254601B1 (en) 1998-12-08 2001-07-03 Hysterx, Inc. Methods for occlusion of the uterine arteries
US6550482B1 (en) 2000-04-21 2003-04-22 Vascular Control Systems, Inc. Methods for non-permanent occlusion of a uterine artery
US7223279B2 (en) 2000-04-21 2007-05-29 Vascular Control Systems, Inc. Methods for minimally-invasive, non-permanent occlusion of a uterine artery
US6635065B2 (en) 2000-11-16 2003-10-21 Vascular Control Systems, Inc. Doppler directed suture ligation device and method
US6638286B1 (en) 2000-11-16 2003-10-28 Vascular Control Systems, Inc. Doppler directed suture ligation device and method
EP1377223A2 (en) * 2001-03-28 2004-01-07 Vascular Control Systems, Inc. Method and apparatus for the detection and ligation of uterine arteries
US7354444B2 (en) 2001-03-28 2008-04-08 Vascular Control Systems, Inc. Occlusion device with deployable paddles for detection and occlusion of blood vessels
US7207996B2 (en) * 2002-04-04 2007-04-24 Vascular Control Systems, Inc. Doppler directed suturing and compression device and method
US7172603B2 (en) * 2002-11-19 2007-02-06 Vascular Control Systems, Inc. Deployable constrictor for uterine artery occlusion
US20040097961A1 (en) * 2002-11-19 2004-05-20 Vascular Control System Tenaculum for use with occlusion devices
US7404821B2 (en) 2003-01-30 2008-07-29 Vascular Control Systems, Inc. Treatment for post partum hemorrhage
US7651511B2 (en) 2003-02-05 2010-01-26 Vascular Control Systems, Inc. Vascular clamp for caesarian section
US7333844B2 (en) 2003-03-28 2008-02-19 Vascular Control Systems, Inc. Uterine tissue monitoring device and method
US7325546B2 (en) * 2003-11-20 2008-02-05 Vascular Control Systems, Inc. Uterine artery occlusion device with cervical receptacle
US7686817B2 (en) 2003-11-25 2010-03-30 Vascular Control Systems, Inc. Occlusion device for asymmetrical uterine artery anatomy
US20060015144A1 (en) * 2004-07-19 2006-01-19 Vascular Control Systems, Inc. Uterine artery occlusion staple
US7875036B2 (en) 2004-10-27 2011-01-25 Vascular Control Systems, Inc. Short term treatment for uterine disorder
WO2009033781A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
WO2009033792A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent
CN101555274B (zh) * 2009-05-15 2013-08-21 海南双成药业股份有限公司 一种多肽固相合成比法卢定粗品的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116818A (en) * 1987-03-10 1992-05-26 Medical College Of Hampton Roads Method and kit for contraception with GnRH-antagonist
DK0477499T3 (da) * 1990-08-04 1994-05-30 Hoechst Ag Gonadoliberin-antagonister
US5780435A (en) 1995-12-15 1998-07-14 Praecis Pharmaceuticals Incorporated Methods for treating prostate cancer with LHRH-R antagonists

Also Published As

Publication number Publication date
DE69724682D1 (de) 2003-10-16
EP0796622A3 (en) 1999-02-24
USRE40119E1 (en) 2008-02-26
ES2206622T3 (es) 2004-05-16
US5691314A (en) 1997-11-25
PT796622E (pt) 2003-12-31
EP0796622A2 (en) 1997-09-24
ATE249233T1 (de) 2003-09-15
EP0796622B1 (en) 2003-09-10
DE69724682T2 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
DK0796622T3 (da) Anvendelse af en gonadotropin-frigivende hormonanalog eller efterligning deraf til fremstilling af et farmaceutisk præparat som et supplement til den invasive behandling af carcinomer
DE69839586D1 (de) Verwendung von ingenan derivaten zur herstellung eines medikaments zur krebsbekämpfung
HUP0000838A2 (hu) Szteroid-glikozidot tartalmazó extraktum, eljárás izolálására és szintetikus előállítására, valamint ezt tartalmazó étvágycsökkentő gyógyszerkészítmények
ATE76296T1 (de) Pharmazeutische zusammensetzung zur behandlung von akuter myocardischer ischaemie.
DE3485581D1 (de) Antioestrogenes arzneimittel zur perkutanen verabreichung.
HUP9901246A2 (hu) Növekedési hormon kiválasztását elősegítő vegyületek
KR890000101A (ko) 반월조직의 치료 개선방법 및 치료약제
EP0206291A3 (en) Sprayable pharmaceutical preparation for topical application
KR950031060A (ko) 골다공증 치료용 약제학적 조성물
DE60134816D1 (de) Extrakte, Wirkstoffe und pharmazeutische Präparate mit antidiabetischen Eigenschaften und ihre Verwendung
SE9301290D0 (sv) Anvaendning av en somatostatinanalog
EP0009688A3 (en) Medicated animal food based on liver powder, process for its preparation and its use in combating animal diseases
PH27446A (en) Compound with gastric acid inhibitory effect
BR9911756A (pt) Composto, uso de um secretagogo do hormÈnio do crescimento ou um seu sal farmaceuticamente aceitável, composição farmacêutica, método para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero, e, uso de um composto
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
AU6483286A (en) Prazosin-pirbuterol combination for bronchoduation
AR008695A1 (es) Composiciones farmaceuticas estabilizadas, basadas en la asociacion de quinupristina / dalfopristina; procedimiento para prepararlas, utilizacion dedichas composiciones y utilizacion del acido metansulfonico o del acido clorhidrico en la estabilizacion de dichas composiciones.
AR036591A1 (es) Uso de la hl en hiperestimulacion ovarica controlada
NO910033L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-3-fenoksypropylaminoforbindelser.
AR008245A1 (es) Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados
BR9906975A (pt) Composto, uso do mesmo, composição farmacêutica, e, processo para estimular a liberação do hormÈnio do crescimento pela pituitária de um mamìfero
DK0541726T3 (da) Vækstfaktorsammensætninger, fremstilling og anvendelse
AU4831279A (en) New compounds
ATE262538T1 (de) Lhrh-analoga zur behandlung der osteoporose
ATE329613T1 (de) Wachstumhormone inhibitoren enthaltende pharmazeutische zubereitungen oder ihre biologisch aktive fragmente zur behandlung von uterinen myomas